S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
MSFT   140.41 (-0.82%)
GOOGL   1,243.00 (+0.06%)
AMZN   1,777.43 (+0.57%)
CGC   19.73 (-1.84%)
NVDA   194.21 (-1.10%)
MU   45.16 (-2.80%)
BABA   177.12 (+1.04%)
GE   8.90 (+0.11%)
TSLA   259.75 (+0.72%)
AMD   30.81 (+0.29%)
T   37.79 (-0.29%)
F   9.07 (+0.00%)
ACB   3.61 (-3.99%)
PRI   123.87 (+0.16%)
NFLX   286.28 (+0.71%)
BAC   30.17 (+1.48%)
GILD   65.35 (+0.08%)
DIS   130.86 (+0.85%)
Log in

Cronos Group Stock Price, News & Analysis (TSE:CRON)

C$11.03
+0.03 (+0.27 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
C$10.36
Now: C$11.03
C$11.30
50-Day Range
C$10.37
MA: C$13.32
C$15.86
52-Week Range
C$8.47
Now: C$11.03
C$32.95
Volume788,472 shs
Average Volume1.52 million shs
Market CapitalizationC$3.71 billion
P/E Ratio15.51
Dividend YieldN/A
BetaN/A
Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone416-504-0004

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$26.07 million
Cash FlowC$7.35 per share
Book ValueC$3.64 per share

Profitability

Miscellaneous

Employees291
Market CapC$3.71 billion
Next Earnings Date11/12/2019 (Estimated)
OptionableOptionable

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.


Cronos Group (TSE:CRON) Frequently Asked Questions

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Cronos Group.

What price target have analysts set for CRON?

7 analysts have issued 1 year price targets for Cronos Group's stock. Their predictions range from C$10.00 to C$27.00. On average, they anticipate Cronos Group's stock price to reach C$19.44 in the next year. This suggests a possible upside of 76.3% from the stock's current price. View Analyst Price Targets for Cronos Group.

What is the consensus analysts' recommendation for Cronos Group?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cronos Group.

Has Cronos Group been receiving favorable news coverage?

News coverage about CRON stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cronos Group earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Cronos Group.

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria (APHA), Netflix (NFLX), Aphria (APHA), Tilray (TLRY) and GW Pharmaceuticals PLC- (GWPH).

Who are Cronos Group's key executives?

Cronos Group's management team includes the folowing people:
  • Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)
  • Mr. David Hsu, Chief Operating Officer
  • Ms. Xiuming Shum, Gen. Counsel & Corp. Sec.
  • Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.
  • Mr. William Hilson, Chief Commercial Officer

How do I buy shares of Cronos Group?

Shares of CRON and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$11.03.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of C$3.71 billion and generates C$26.07 million in revenue each year. Cronos Group employs 291 workers across the globe.View Additional Information About Cronos Group.

What is Cronos Group's official website?

The official website for Cronos Group is http://www.thecronosgroup.com/.

How can I contact Cronos Group?

The company can be reached via phone at 416-504-0004.


MarketBeat Community Rating for Cronos Group (TSE CRON)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  59 (Vote Underperform)
Total Votes:  106
MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe CRON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Bar Chart

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel